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Defining the host mucosal and gut microflora interactions in Crohn's disease 
using redundancy analysis on microarray datasets 
Abstract 
Introduction: Crohn’s disease (CD) is an inflammatory bowel disease that is characterised by chronic 
relapsing inflammation of the digestive tract. There is a significant body of evidence that suggests the 
intestinal mucosal microbiome interacts with the immune response to produce pathological inflammation 
and together these factors play a major role in the pathogenesis of CD. The aim of this study is to 
investigate interactions between the human intestinal mucosal transcriptome and mucosal microbiome 
using multivariate redundancy analysis on microarray datasets. 
Methods: DNA and RNA were extracted from the same mucosal biopsies collected from CD patients 
(terminal ileum: n=5 from sites with active disease, n=4 from inactive sites (tissue with normal histology); 
colon: n=8 from active and n=6 from inactive sites). RNA was used to study the human intestinal mucosal 
transcriptome (Affymetrix GeneChip® Exon 1.0 ST arrays) and DNA was used to study the resident 
microbiota using a custom phylogenetic microarray. The latter was designed using published 
gastrointestinal microbiota 16S rRNA sequences with ~ 40-mer oligonucleotides targeting 765 bacterial 
species. Through examining the expression arrays, 30 differentially expressed inflammatory response 
genes of interest were selected. Correlations between expression patterns for these genes were 
assessed. Representatives (TNFRSF1B, IL2RA, IL8) of three groups of inflammatory genes with highly 
correlated expression and three uncorrelated genes of interest (CXCL11, IL- 13RA1 and TIRAP) were used. 
Multivariate relationships between the expression of the six representative inflammatory response genes 
and the abundance of microbial species in colon or terminal ileum, in patients with active or inactive 
disease was examined using redundancy analysis using the vegan package in R1. Correlations between 
the expression of individual inflammatory response genes and the abundance of individual microbes were 
also investigated. 
Results: There appears to be a significant relationship between changes in the abundance of some 
microbial species in intestinal mucosa with active disease and the expression of the six representative 
inflammatory response genes. However, this was not the case in the normal (inactive) mucosa of these 
patients. Where there was active disease the expression of the six genes were predicted by members of 
the sulfite-reducing bacteria Clostridia class (p-value 0.02-0.005) in the colon, and the Betaproteobacteria 
(p-value 0.02) and Clostridia (p-value 0.03) class members in the ileum. In the normal (inactive) mucosa 
of CD patients, there were no bacterial species that significantly predicted the expression of inflammatory 
immune response genes. There was also some evidence that the expression of the pro-inflammatory 
cytokine, IL8, predicted changes in the abundance of microbes in inactive colon (p-value 0.04) and that 
TIRAP (toll-Il1 receptor domain containing adaptor protein), involved in the innate immune system’s 
recognition of microbial pathogens, was predictive of the pattern of microbial abundance in active ileum 
(p-value 0.05). 
Conclusions: Our findings begin to define the unique hostmicrobial responses associated with CD. 
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microflora interactions in Crohn’s disease 
using redundancy analysis on microarray 
datasets
Introduction: Crohn’s disease (CD) is an inflammatory bowel 
disease that is characterised by chronic relapsing inflammation 
of the digestive tract. There is a significant body of evidence that 
suggests the intestinal mucosal microbiome interacts with the 
immune response to produce pathological inflammation and 
together these factors play a major role in the pathogenesis 
of CD. The aim of this study is to investigate interactions 
between the human intestinal mucosal transcriptome and 
mucosal microbiome using multivariate redundancy analysis on 
microarray datasets.
Methods: DNA and RNA were extracted from the same mucosal 
biopsies collected from CD patients (terminal ileum: n=5 from 
sites with active disease, n=4 from inactive sites (tissue with 
normal histology); colon: n=8 from active and n=6 from inactive 
sites). RNA was used to study the human intestinal mucosal 
transcriptome (Affymetrix GeneChip® Exon 1.0 ST arrays) 
and DNA was used to study the resident microbiota using a 
custom phylogenetic microarray. The latter was designed using 
published gastrointestinal microbiota 16S rRNA sequences 
with ~ 40-mer oligonucleotides targeting 765 bacterial species. 
Through examining the expression arrays, 30 differentially 
expressed inflammatory response genes of interest were 
selected. Correlations between expression patterns for these 
genes were assessed. Representatives (TNFRSF1B, IL2RA, IL8) 
of three groups of inflammatory genes with highly correlated 
expression and three uncorrelated genes of interest (CXCL11, IL-
13RA1 and TIRAP) were used. Multivariate relationships between 
the expression of the six representative inflammatory response 
genes and the abundance of microbial species in colon or 
terminal ileum, in patients with active or inactive disease was 
examined using redundancy analysis using the vegan package 
in R1. Correlations between the expression of individual 
inflammatory response genes and the abundance of individual 
microbes were also investigated.
Results: There appears to be a significant relationship between 
changes in the abundance of some microbial species in 
intestinal mucosa with active disease and the expression of 
the six representative inflammatory response genes. However, 
this was not the case in the normal (inactive) mucosa of these 
patients. Where there was active disease the expression of the 
six genes were predicted by members of the sulfite-reducing 
bacteria Clostridia class (p-value 0.02-0.005) in the colon, and 
the Betaproteobacteria (p-value 0.02) and Clostridia (p-value 
0.03) class members in the ileum. In the normal (inactive) 
mucosa of CD patients, there were no bacterial species that 
significantly predicted the expression of inflammatory immune 
response genes. There was also some evidence that the 
expression of the pro-inflammatory cytokine, IL8, predicted 
changes in the abundance of microbes in inactive colon (p-value 
0.04) and that TIRAP (toll-Il1 receptor domain containing 
adaptor protein), involved in the innate immune system’s 
recognition of microbial pathogens, was predictive of the 
pattern of microbial abundance in active ileum (p-value 0.05).
Conclusions: Our findings begin to define the unique host-
microbial responses associated with CD.
